当前位置：
X-MOL 学术
›
Clin. Infect. Dis.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Gepotidacin for the Treatment of Uncomplicated Urogenital Gonorrhea: A Phase 2, Randomized, Dose-Ranging, Single-Oral Dose Evaluation
Clinical Infectious Diseases ( IF 11.8 ) Pub Date : 2018-04-02 , DOI: 10.1093/cid/ciy145 Stephanie N Taylor 1 , David H Morris 2 , Ann K Avery 3 , Kimberly A Workowski 4 , Byron E Batteiger 5 , Courtney A Tiffany 6 , Caroline R Perry 6 , Aparna Raychaudhuri 6 , Nicole E Scangarella-Oman 6 , Mohammad Hossain 6 , Etienne F Dumont 6
Clinical Infectious Diseases ( IF 11.8 ) Pub Date : 2018-04-02 , DOI: 10.1093/cid/ciy145 Stephanie N Taylor 1 , David H Morris 2 , Ann K Avery 3 , Kimberly A Workowski 4 , Byron E Batteiger 5 , Courtney A Tiffany 6 , Caroline R Perry 6 , Aparna Raychaudhuri 6 , Nicole E Scangarella-Oman 6 , Mohammad Hossain 6 , Etienne F Dumont 6
Affiliation
In this phase 2 study, we evaluated the efficacy and safety of oral gepotidacin, a novel triazaacenaphthylene bacterial type II topoisomerase inhibitor, for the treatment of uncomplicated urogenital gonorrhea.
中文翻译：
Gepotidacin用于治疗单纯性泌尿生殖道淋病：2期，随机，剂量范围，单口服剂量评估
在此2期研究中，我们评估了口服吉普达星（一种新型的三氮杂ac烯细菌II型拓扑异构酶抑制剂）治疗单纯性泌尿生殖道淋病的疗效和安全性。
更新日期：2018-04-02
中文翻译：
Gepotidacin用于治疗单纯性泌尿生殖道淋病：2期，随机，剂量范围，单口服剂量评估
在此2期研究中，我们评估了口服吉普达星（一种新型的三氮杂ac烯细菌II型拓扑异构酶抑制剂）治疗单纯性泌尿生殖道淋病的疗效和安全性。
京公网安备 11010802027423号